MRI were bilateral only in one patient with HSVE. The defects in the three patients with adenovirus infection were severe and resembled the amnesia after HSVE. Cognitive impairment, not previously reported, was found in encephalitis after rotavirus infection and epidemic nephropathy. Conclusion-The recovery in the HSVE group was better than expected based on the medical literature. On the other hand there were surprisingly severe cognitive defects in encephalitis after other viruses.
With early acyclovir treatment patients with the least severe HSVE were equivalent to those with non-HSV encephalitis with good outcome whereas those with the most severe non-HSV encephalitis were equivalent to those with HSVE with poor outcome. brain parenchyma, in most patients caused by viral agents, although bacterial, other microbial, and postinfectious forms are known. In the United States 20 000 cases occur each year.' In Finland the prevalence of meningoencephalitis and encephalitis is estimated to be 3-5 cases per 100 000. 2 The aetiology may be difficult to determine and one third to two thirds of the patients lack specific microbial confirmation.3 4 Worldwide, the arboviruses are the most frequent cause of epidemics of encephalitis. In western Europe sporadic infections account for most cases, and the most common single aetiology is herpes simplex 1 virus. In Sweden the incidence of herpes simplex encephalitis (HSVE) is at least 2-3 cases per million inhabitants per year. 6 Mental changes as an initial consequence of encephalitis have been reported in all epidemiological studies. 478 The cognitive defects that persist after the acute stage have seldom been reported in detail. In studies from the United States, the United Kingdom, and Germany the frequency of residual neurological disability has been 10%-30%, including aphasia, mental deterioration, and paralysis.3479 Neuropsychological investigation was not used in any of these studies.
It has been reported that HSVE results in bilateral temporal lobe damage'O1 ' and persistent memory defect.'2 'I The outcome has been considered poor; death or severe disablement and dependency being the common end points.'4 15 Most of the reported cases originate from the 1970s and early 1980s and since then acyclovir treatment has changed the prognosis of this disease.6 Early treatment may have an effect on the long term neuropsychological symptomatology as well, but only small series have so far been published. '6 18 Even fewer reports have described the neuropsychological findings in acute encephalitis of other aetiologies. In the United States, HSVE accounts for 5%-10% of the annual cases of encephalitis.' In the German series of and pathological s/CSF CF = fourfold increase in the antibody titre in paired samples using the complement fixation test; EIA = twofold increase in the antibody titre in paired samples using the enzyme linked immunosorbent assay; PCR = polymerase chain reaction; ab = antibody; s/CSF = serum/CSF ratio.
age of 75 with acute encephalitis were referred for neuropsychological examination at the Department of Neurology, Helsinki University Central Hospital. It is the only hospital with 24 hour neurological emergency services in the province of Uusimaa (population 1 million), and thus the material includes nearly all adult patients with serious CNS infections in this area during this time. The diagnosis of encephalitis was based on the history, clinical physical and mental findings, and EEG suggesting involvement of the brain parenchyma, findings compatible with infection of the CNS, and CT excluding other causes. Fifteen patients with alcohol misuse, or coexisting or previous neurological disease were excluded. Thus 77 patients with acute encephalitis without concomitant conditions were analysed.
The aetiology was established in 44 (57%). The analyses were carried out at the Department of Virology, University of Helsinki. Table 1 gives the methods for reaching specific diagnoses. The polymerase chain reaction (PCR) method for the detection of herpes simplex virus-DNA was used in nine patients during 1993-4. Seventeen patients had herpes simplex 1 virus encephalitis (HSVE), nine had varicella zoster virus encephalitis (VZVE), and one had herpes simplex 2 virus (HSV-2) encephalitis. Seventeen had some other identified non-herpetic aetiology as the underlying cause for the encephalitis. The patients were grouped as the HSVE group (n = 17), the non-HSVE group (n = 27), and the unspecified group (n = 33).
Follow up EEG and standard laboratory tests were performed on all patients. Neuroradiological follow up was performed using CT in 18 patients and MRI in 31 patients. For analysis, the CT and MRI were scored blindly by two neuroradiologists (OS and LV). In the first CT, which was performed within the first three days in most patients, cortical or central atrophy was found in 16 of 77 patients (20%). At follow up, CT or MRI disclosed newly developed focal atrophy or focal lesions in 28 (36%) patients.
All patients received specific antibiotic treatment. Along with other medication, 73, including all patients with HSVE, were given intravenous acyclovir (30 mg/kg per day) for a mean of 11-2 (SD 4-1) days. One patient with influenza B, one with tick borne encephalitis virus, one with epidemic nephropathy, and one with suspicion of tuberculous meningoencephalitis were treated accordingly, without acyclovir medication. In the HSVE group acyclovir treatment was started on the same day as the mental symptoms appeared in two patients, on the next day in five patients, on day 2 in three patients, on day 3 in one patient, on day 4 in one patient, and five or more days after the onset in five patients.
The duration of stay in hospital was 36-4 (SD 38 2), range 8-213 days. After that the patients visited the hospital if necessary. The follow up extended up to the time of subsequent return to work or a decision to retire, maximally one year.
The performance of the patients in the neuropsychological investigation was compared with that of a group of 29 nornmal controls. Twenty five of the controls had initially volunteered for a study of quantitative EEG (Q-EEG) and were later willing to participate further. One control was excluded due to a history of probable meningitis. The others had no medical problems and their Q-EEG was normal. Five of the controls were additional volunteers who had no medical complaints and whose neurological examination was normal. Table 2 shows distributions of age, sex, and education for the HSVE, non-HSVE, and the control groups. There was no difference in age or duration of education between the three groups (analysis of variance, ANOVA). There was a difference in the Beck depression inventory (BDI) score at the time of the neuropsychological investigation (mean 7-2 (7-8) in the HSVE group, 6-9 (7 8) in the non-HSVE group, 2-1 (2-4) in the control group, F = 5-18, P < 0 01). Pairwise post hoc analyses disclosed a higher depression score in patients than in controls (P < 0-02, Tukey's honest significant difference), but no difference between the HSVE and the non-HSVE groups. There was no difference between the HSVE and non-HSVE groups in the frequency of brain atrophy or focal lesions found in the first CT (Pearson's x2 test). Fourteen patients with HSVE (82%) had focal lesions in the follow up neuroradiology, whereas the corresponding frequency for the non-HSVE group was 15% (Pearson's X2 = 19-7, P < 0-0001). Table 2 gives the radiological findings.
To rule out the possibility of error due to selection, we also compared the patients with aetiologically specified encephalitis (both HSVE and non-HSVE, n = 44) with the patients with non-specified encephalitis (n = 33). Age, duration of education, and depression scores were similar in the two groups (Student's t test).
NEUROPSYCHOLOGICAL ASSESSMENT
The neuropsychological examination was carried out in a postacute stage, as soon as the initial confusion had subsided and the patient could cooperate adequately. This was a mean 27-5 (22 8), range 5-128 days, after the onset of symptoms. The controls underwent a similar neuropsychological examination. The occurrence of neuropsychological findings in the HSVE group (n = 17) was compared with that in the non-HSVE group (n = 27), and risk ratios as well as 95% confidence intervals were calculated. The findings in patients with non-herpetic encephalitis are also given in detail. Cases of unspecified aetiology were omitted from these analyses.
Results
Significant psychometric differences were found between the HSVE, the non-HSVE, and the control groups (ANOVA: VIQ F (2, 69) = 10-2, P < 0-001; PIQ F (2, 69) = 20 9, P < 0-001; verbal memory F (2, 66) = 38-8, P < 0-001; and visual memory F (2, 63) = 21-4, P < 0-001). In pairwise comparison (Tukey's honest significant difference, Spjotvoll/Stoline test), both the HSVE and the non-HSVE group performed worse than the controls in all tests (P < 005). In the verbal and the visual memory the HSVE group was more impaired than the non-HSVE group (P < 0-001). Table 3 gives the neuropsychological findings. 
test).
No differences in any of the cognitive measures were found between patients with a specified aetiology (both HSVE and non- This study did not include all patients treated for acute encephalitis in the Department of Neurology. It consisted of those referred for neuropsychological examination. Patients who died in the early phase were not included. On the other hand, a few patients without specific aetiological diagnosis who were discharged rapidly due to mild course of disease were also left out. Therefore, the possible bias in the inclusion of cases is bidirectional and probably does not distort the results. Also the fact that only specified aetiologies were included in the analyses might produce error. However, the patients with a specified encephalitis had neither more nor less cognitive defects than the patients with non-specified encephalitis, and the percentage of patients later returning to work was similar in these groups. 
